WO2012047007A3 - Composition for promoting fingernail or toenail growth - Google Patents

Composition for promoting fingernail or toenail growth Download PDF

Info

Publication number
WO2012047007A3
WO2012047007A3 PCT/KR2011/007352 KR2011007352W WO2012047007A3 WO 2012047007 A3 WO2012047007 A3 WO 2012047007A3 KR 2011007352 W KR2011007352 W KR 2011007352W WO 2012047007 A3 WO2012047007 A3 WO 2012047007A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
fingernail
promoting
toenail growth
toenail
Prior art date
Application number
PCT/KR2011/007352
Other languages
French (fr)
Korean (ko)
Other versions
WO2012047007A2 (en
Inventor
김형준
박원석
박필준
김범준
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to CN201180053494.4A priority Critical patent/CN103189041B/en
Publication of WO2012047007A2 publication Critical patent/WO2012047007A2/en
Publication of WO2012047007A3 publication Critical patent/WO2012047007A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a composition for promoting fingernail or toenail growth, containing valproic acid or a pharmaceutically acceptable salt as an active ingredient. In addition, disclosed are pharmaceutical and cosmetic compositions containing the composition.
PCT/KR2011/007352 2010-10-06 2011-10-05 Composition for promoting fingernail or toenail growth WO2012047007A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201180053494.4A CN103189041B (en) 2010-10-06 2011-10-05 Fingernail or toenail growth composition for promoting

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100097376A KR101733189B1 (en) 2010-10-06 2010-10-06 Composition for promotion of growing nail or toenail
KR10-2010-0097376 2010-10-06

Publications (2)

Publication Number Publication Date
WO2012047007A2 WO2012047007A2 (en) 2012-04-12
WO2012047007A3 true WO2012047007A3 (en) 2012-07-05

Family

ID=45928213

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/007352 WO2012047007A2 (en) 2010-10-06 2011-10-05 Composition for promoting fingernail or toenail growth

Country Status (3)

Country Link
KR (1) KR101733189B1 (en)
CN (1) CN103189041B (en)
WO (1) WO2012047007A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102021734B1 (en) * 2018-05-24 2019-09-16 김선희 Correcting method for ingrowing nail and protective coating agent used the method
US20220354783A1 (en) * 2018-08-01 2022-11-10 Edix-O Sarl Injectable prolonged-action compositions for use in the treatment of nail disease and/or for promoting nail growth

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0133110A1 (en) * 1983-07-20 1985-02-13 Sanofi Pharmaceutical composition on the basis of valproic acid, and its manufacturing process
KR20030036691A (en) * 2000-08-17 2003-05-09 테바 파마슈티컬 인더스트리즈 리미티드 Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
JP2005512961A (en) * 2001-09-18 2005-05-12 ゲー・ツヴァイ・エム キャンサー ドラッグス アー・ゲー Valproic acid and its derivatives for combination therapy treatment of human cancer and treatment of tumor metastasis and minimal residual disease
US20090186809A1 (en) * 2006-03-31 2009-07-23 Topotarget Germany Ag Use of valproic acid for the topical treatment of mild to moderate acne vulgaris

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0133110A1 (en) * 1983-07-20 1985-02-13 Sanofi Pharmaceutical composition on the basis of valproic acid, and its manufacturing process
KR20030036691A (en) * 2000-08-17 2003-05-09 테바 파마슈티컬 인더스트리즈 리미티드 Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
JP2005512961A (en) * 2001-09-18 2005-05-12 ゲー・ツヴァイ・エム キャンサー ドラッグス アー・ゲー Valproic acid and its derivatives for combination therapy treatment of human cancer and treatment of tumor metastasis and minimal residual disease
US20090186809A1 (en) * 2006-03-31 2009-07-23 Topotarget Germany Ag Use of valproic acid for the topical treatment of mild to moderate acne vulgaris

Also Published As

Publication number Publication date
KR101733189B1 (en) 2017-05-08
CN103189041B (en) 2015-09-30
WO2012047007A2 (en) 2012-04-12
CN103189041A (en) 2013-07-03
KR20120035691A (en) 2012-04-16

Similar Documents

Publication Publication Date Title
WO2012021715A3 (en) Stable formulations of linaclotide
WO2009101503A3 (en) Use of natural active substances in cosmetic or therapeutic compositions
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
HK1243630A1 (en) Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
WO2011106493A3 (en) Oral care compositions comprising magnolia bark extract or a synthetic analog thereof
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
WO2011122869A3 (en) Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care
WO2012130820A3 (en) Isopentyl esters for the use in cosmetic, dermatological, or pharmaceutical compositions
WO2010021607A3 (en) Pharmaceutical formulation
WO2012161497A3 (en) Peptide derivatives having a superior moisturizing effect and uses thereof
WO2012064126A3 (en) Medical adhesive composition
PT2459153E (en) Pharmaceutical or cosmetic or dietetic composition for promoting a hair pigmentation effect
WO2011141488A3 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
WO2012002730A3 (en) Skin-whitening and skin-moisturizing composition containing bee venom extracts
EA201201109A1 (en) ELECTRIC WOOD IN THIN-CUT CRYSTALLINE FORM AND PHARMACEUTICAL COMPOSITION CONTAINING
WO2012053009A3 (en) Pharmaceutical compositions comprising nano size droplets of skin whitening agents
IL222419A0 (en) Novel formulations of active ingredient (s) of plant origin or synthetic analogues thereof or of extract (s) of plant origin containing same, and of lecitihin
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
WO2011002422A3 (en) Solubility enhancing pharmaceutical formulation
WO2012052478A3 (en) Topical gel composition
WO2011107866A3 (en) Silyl-derivatives of polysaccharides
MX2014014579A (en) O/w-emulsion-type topical pharmaceutical compositions containing a retinoid.
EP2871187A4 (en) Novel compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient
WO2011139252A3 (en) Efervescent formulations comprising cefdinir
WO2010061220A3 (en) Novel processes and pure polymorphs

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11830892

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 17/07/2013)

122 Ep: pct application non-entry in european phase

Ref document number: 11830892

Country of ref document: EP

Kind code of ref document: A2